You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pharmacogenomic

Showing 1 - 25 of 479
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Depression, Pain Trial in Charlotte (Preemptive Pharmacogenomic Testing)

Enrolling by invitation
  • Cancer
  • +2 more
  • Preemptive Pharmacogenomic Testing
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 31, 2023

Malignant Tumor of Ill-defined Site Trial in Charlotte (Pharmacogenomic Testing)

Terminated
Has Results
  • Malignant Tumor of Ill-defined Site
  • Pharmacogenomic Testing
  • Charlotte, North Carolina
    Levine Cancer Institute
Nov 1, 2022

Hematopoietic Cell Transplantation, Oncology Trial in Charlotte (Pharmacogenomic-guided supportive care)

Recruiting
  • Hematopoietic Cell Transplantation
  • Oncology
  • Pharmacogenomic-guided supportive care
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 26, 2023

Gastrointestinal Cancer, Breast Cancer, Head Neck Cancer Trial in Chicago (Pharmacogenomics (PGx) Testing and Genomics

Recruiting
  • Gastrointestinal Cancer
  • +4 more
  • Availability of clinical decision support based on pharmacogenomic results.
  • Chicago, Illinois
    University of Chicago Medical Center
Oct 20, 2022

Gastrointestinal Diseases Trial in Rochester (Pharmacogenomics (PGx) genetic testing)

Completed
  • Gastrointestinal Diseases
  • Pharmacogenomics (PGx) genetic testing
  • Rochester, Minnesota
    Mayo Clinic Rochester
Oct 5, 2022

Implementation ofPharmacist-led Pharmacogenomic Clinical Service

Enrolling by invitation
  • Adverse Drug Event
  • +3 more
  • Pharmacogenomic Testing
  • Orlando, Florida
    Tabula Rasa HealthCare Precision Pharmacotherapy Research and De
Jun 13, 2022

Antidepressants Causing Adverse Effects in Therapeutic Use Trial in Ann Arbor (PGx test)

Completed
  • Antidepressants Causing Adverse Effects in Therapeutic Use
  • PGx test
  • Ann Arbor, Michigan
    University of Michigan
May 16, 2022

Depressive Disorder, Pharmacogenomic Drug Interaction Trial in Hangzhou (pharmacogenomic testing)

Completed
  • Depressive Disorder
  • Pharmacogenomic Drug Interaction
  • pharmacogenomic testing
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Jul 17, 2023

Major Depressive Disorder:Observational Prospective RAndomized,

Recruiting
  • Major Depressive Disorder
  • Pharmacogenomics test (PGx)
  • Brescia, BS, Italy
    Department of Mental Health and Addiction
Sep 12, 2022

Integrating Pediatric Pharmacogenomic Testing Into Canadian

Recruiting
  • Adverse Drug Reaction (ADR)
    • Vancouver, British Columbia, Canada
    • +1 more
    Nov 3, 2022

    Renal Transplant Trial in Chapel Hill (Tacrolimus)

    Completed
    Has Results
    • Renal Transplant
    • Chapel Hill, North Carolina
      Univeristy of North Carolina
    Jul 18, 2022

    Pain Trial in Rochester (Pharmacogenomic Testing, Ibuprofen, hydroxycontin/acetominophen)

    Terminated
    Has Results
    • Pain
    • Pharmacogenomic Testing
    • +4 more
    • Rochester, New York
      Eastman Institute for Oral Health
    Mar 15, 2022

    Polypharmacy Trial in Aurora (Pharmacogenomic test)

    Active, not recruiting
    • Polypharmacy
    • Pharmacogenomic test
    • Aurora, Colorado
      Central Support Services
    Mar 15, 2022

    Tuberculosis Infection, Isoniazid Adverse Reaction Trial (Low-dose isoniazid, Standard dose of isoniazid, High-dose isoniazid)

    Not yet recruiting
    • Tuberculosis Infection
    • Isoniazid Adverse Reaction
    • Low-dose isoniazid
    • +2 more
    • (no location specified)
    Jun 7, 2022

    Thrombosis, Stent Thrombosis, Bleeding Trial in Edinburg (Cipherome Lighthouse Pilot)

    Recruiting
    • Thrombosis
    • +4 more
    • Cipherome Lighthouse Pilot
    • Edinburg, Texas
    • +1 more
    Jul 18, 2022

    Metastatic Carcinoma in the Adrenal Cortex, Stage III Adrenal Cortex Carcinoma AJCC v8, Stage IV Adrenal Cortex Carcinoma AJCC

    Active, not recruiting
    • Metastatic Carcinoma in the Adrenal Cortex
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 12, 2022

    Pharmacogenetics, Anesthesia Trial (Pharmacogenomic optimisation of anaesthetic medications)

    Not yet recruiting
    • Pharmacogenetics
    • Anesthesia
    • Pharmacogenomic optimisation of anaesthetic medications
    • (no location specified)
    Sep 28, 2021

    Depression, Anxiety, Generalized Anxiety Disorder Trial in Tampa (DNA-guided choice of therapy, Clinical management)

    Active, not recruiting
    • Depression
    • +5 more
    • DNA-guided choice of therapy
    • Clinical management
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Mar 23, 2022

    Pharmacogenomic Testing inProgram of All-inclusive Care for

    Enrolling by invitation
    • Pharmacogenomics
    • Polypharmacy
    • Pharmacogenomic Testing
    • Orlando, Florida
      Tabula Rasa HealthCare Precision Pharmacotherapy Research and De
    Dec 17, 2021

    Adverse Drug Reaction Trial in Worldwide (Pharmacogenomic testing)

    Completed
    • Adverse Drug Reaction
    • Pharmacogenomic testing
    • Vienna, Austria
    • +6 more
    Apr 15, 2022

    Pediatric Acute Lymphoblastic Leukemia

    Enrolling by invitation
    • Acute Lymphoblastic Leukemia, Pediatric
    • Adverse Drug Event
      • Stanford, California
        Stanford University
      Mar 7, 2022

      Information Seeking Behavior Trial in Chicago

      Recruiting
      • Information Seeking Behavior
        • Chicago, Illinois
        • +1 more
        Jan 7, 2022

        Surgery Trial in Chicago (procedure, diagnostic test, other)

        Recruiting
        • Surgery
        • Routine Elective Surgery- In patient or out patient elective surgery
        • +2 more
        • Chicago, Illinois
          University Of Chicago Medicine Comprehensive Cancer Center
        Jan 7, 2022

        Perioperative/Postoperative Complications Trial in Phoenix (Pharmacogenomic (PGx), Review results)

        Completed
        • Perioperative/Postoperative Complications
        • Pharmacogenomic (PGx)
        • Review results
        • Phoenix, Arizona
          Mayo Clinic in Arizona
        Jun 13, 2022

        HMG-CoA Reductase Inhibitor Toxicity Trial in Kansas City (Exercise)

        Recruiting
        • HMG-CoA Reductase Inhibitor Toxicity
        • Exercise
        • Kansas City, Kansas
          University of Kansas Medical Center
        Nov 16, 2021